Comparison

Multiple Sclerosis [MS] vs Visuallusion

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Multiple Sclerosis [MS]

This clinical decision support tool offers evidence-based medical content for healthcare professionals managing Multiple Sclerosis. It uses AI and natural language processing to provide quick, confident answers, improving patient care at the point of need.

Highlights
  • AI-powered clinical decision support
  • Voice-enabled natural language questions
  • Evidence-based, disease-specific content
  • Diagnosis, treatment, and care management topics
  • Case studies, videos, and interviews
  • Continuing medical education credit (CME/CE)
Features
Read full description

@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Sclerosis @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Multiple Sclerosis @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated multiple sclerosis content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients

About

Visuallusion

Explore how the brain processes information through a collection of visual illusions. Learn about neuronal explanations for these phenomena, aiding understanding of neural information processing. This app is utilized in medical education.

Highlights
  • Interactive visual illusions
  • Neuronal explanations
  • Information processing insights
  • Medical education tool
  • Understanding the visual system
Features
Read full description

Visuallusion uses visual illusions to explain how information is processed by the brain. The user can choose from a list of visual illusions. Instructions on what to look for are provided, and the illusion is shown. Explanation of the illusion on a neuronal level is provided, which will assist the user in understanding the basics of neural information processing in the human brain. Vissuallusion is used at the St. Radboud Medical School in Nijmegen, the Netherlands, in a course on the visual system.

Screenshots

Multiple Sclerosis [MS]4 screens
Visuallusion4 screens

Verdict

The call

Multiple Sclerosis [MS] and Visuallusion both sit at 5.0 stars, but that hides the real split: 100% of Visuallusion's written reviews are positive against 62% of Multiple Sclerosis [MS]'s. Visuallusion also leads on iOS requirement (12.0 vs 14.0). Multiple Sclerosis [MS]'s advantage is update cadence (every 5 weeks vs every 8 months). On price, rating, ratings volume and ads there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 5.0 for Multiple Sclerosis [MS] against 5.0 for Visuallusion. Both are backed by a comparable volume of ratings — 1 and 1 respectively. Written reviews are what separate them: 62% of Multiple Sclerosis [MS]'s written reviews are positive against 100% of Visuallusion's.

UpkeepUpdate frequency

Multiple Sclerosis [MS] ships an update every 5 weeks, Visuallusion every 8 months. Both last shipped on November 1, 2026.

Scorecard3 real differences · 7 level
Multiple Sclerosis [MS] versus Visuallusion: the parameters behind the verdict, then further details
ParameterMultiple Sclerosis [MS]Visuallusion
PriceFreeFree
Rating5.0 (1 ratings)5.0 (1 ratings)
Positive reviews61.5% of reviews100.0% of reviews — better
Number of ratings11
Update frequencyEvery 5 weeks — betterEvery 8 months
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS14.012.0 — better
Further details — not scored
Size22 MB2 MB
Age rating12+4+
Developer@Point of CareThom Oostendorp

Customer experience

Multiple Sclerosis [MS]

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews13 reviews
Positive61.5%
Neutral15.4%
Negative23.1%

Visuallusion

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews2 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

Multiple Sclerosis [MS]

No in-app purchases

None

Visuallusion

No in-app purchases

Questions

Is Multiple Sclerosis [MS] free?
Multiple Sclerosis [MS] is free to download, with no in-app purchases.
Is Visuallusion free?
Visuallusion is free to download, with no in-app purchases.
Which has better reviews, Multiple Sclerosis [MS] or Visuallusion?
Multiple Sclerosis [MS] and Visuallusion are both rated 5.0 out of 5 on the App Store, from 1 and 1 ratings respectively.
Do Multiple Sclerosis [MS] or Visuallusion have ads?
Neither Multiple Sclerosis [MS] nor Visuallusion shows ads.
Which is updated more often, Multiple Sclerosis [MS] or Visuallusion?
Multiple Sclerosis [MS] ships an update every 5 weeks, and Visuallusion every 8 months. Most recently, Multiple Sclerosis [MS] was updated on November 1, 2026 and Visuallusion on November 1, 2026.

Other comparisons